The company will submit two emergency use authorization requests, one covering children from 2 to 5 years old, and the second for ages 5 to 11, NPR reported. It’s expected to apply for authorization for the vaccine in children as young as 6 months old in the fourth quarter of this year.
The FDA is expected to authorize use of the vaccine in children between the ages of 12 and 15 as early as next week, according to the Times. Pfizer released data in March showing its vaccine was 100 percent effective in preventing COVID-19 in the age group.
Pfizer also announced it expects to have clinical trial data on the safety of its vaccine in pregnant women by early August, the Times reported.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
